Fangsheng Pharmaceutical's Patch Production Line Passes GMP Compliance Inspection

Regulation
โดย Jiemian·Read original
Summary · why it matters

Fangsheng Pharmaceutical announced that its Patch Workshop 1, Patch Production Line 1, has passed the GMP compliance inspection by the Hunan Medical Products Administration. The production line has a designed capacity of 72 million patches per year, primarily producing loxoprofen sodium gel patches. Previously, subsidiary Guangdong Fangsheng Jianmeng Pharmaceutical had obtained the Drug Registration Certificate for this product.

Impact on stocks 1

Others▲ · 1 stocks
Hunan Fangsheng Pharm Co Ltd
603998
▲ PositiveRegulationrelevance

Patch production line passed GMP compliance inspection, enabling production of loxoprofen sodium gel patches.

Off-coverage companies 1

广东方盛健盟药业Private▲ Positive
Regulationrelevance

Subsidiary previously obtained Drug Registration Certificate for the product, now production line approved.

© 2026 MarketDXNews